UroMed expands female stress incontinence line with Miniguard patch buy.
This article was originally published in The Gray Sheet
Executive SummaryUROMED EXPANDS FEMALE STRESS INCONTINENCE LINE WITH MINIGUARD PATCH acquisition from the Advanced Surgical Intervention Liquidating Trust in a deal valued at $30 mil., the firm announced May 10. UroMed acquired the disposable adhesive patch product and related technology in exchange for $7 mil. in cash and $23 mil. in UroMed common stock. The patch was cleared by FDA via 510(k) on May 8.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.